EPIcyte has licensed patents from the Scripps Research Institute covering new methods of human antibody production in plants that can lower costs up to 100 fold. The company is also developing proprietary products based on its technology, initially, an anti-herpes prophylactic and a contraceptive based on an anti-sperm antibody.

Diametrics is moving beyond the perception that it is an also-ran to point-of-care diagnostics market leader i-Stat, as it stives to become a major player in critical care diagnostics